tirzepatide weight loss program with nurse support Effective Solutions: Semaglutide and Can Tirzepatide Help You Lose

Adults with diabetes

doi: 10.1016/j.lfs.2024.122699 461 YaakoubH.MinaS.CalendaA.BoucharaJ

The authors recommended eye monitoring every 3 months for those at high risk of EWDR during intensive glucose-lowering, although this is not yet included in guidelines

For example, an HFpEF phenotype characterised by pronounced expansion of epicardial adipose tissue (EAT) has been suggested ( Finally, although most of the evidence of a potential benefit of GLP-1 RAs in HF originates from CVOTs in type 2 diabetes, it may likely be in the weight management setting that the drug class could be of the highest clinical value, particularly in people with HFpEF

But they are prescription injectables and come with different risk profiles and medical oversight needs

These symptoms are typically mild to moderate and tend to diminish as the body adjusts to the medication